Inhibition of arterial contraction by dinitrosyl-iron complexes: Critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation

Biochemical Pharmacology

Volumn 66, Issue 12, 2003, Pages 2365-2374

  Alencar, Jacicarlos L ^a,b   Chalupsky, Karel ^a   Sarr, Mamadou ^a   Schini Kerth, Valérie ^a   Vanin, Anatoly F ^c   Stoclet, Jean Claude ^a   Muller, Bernard ^a,d  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

^d INSERM   (France)

Author keywords

Dinitrosyl iron complexes; N Acetylcysteine; Nitric oxide; NO stores; S Nitrosation; Vascular contraction

Indexed keywords

ACETYLCYSTEINE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; CYSTEINE DERIVATIVE; EDETATE SODIUM; GLUTATHIONE DERIVATIVE; IRON COMPLEX; MERCURIC CHLORIDE; NITRIC OXIDE; NITRO DERIVATIVE; S NITROSOTHIOL; SCAVENGER; THIOL DERIVATIVE;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; CHEMICAL BOND; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; MALE; MOLECULAR WEIGHT; NITROSATION; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING;

EID: 0345448064     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.07.017     Document Type: Article

References (38)

1. Henry Y., Lepoivre M., Drapier J.C., Ducrocq C., Boucher J.L., Guissani A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:1993;1124-1134.
2. Vanin AF, Kleschyov AL. EPR detection and biological implications of nitrosyl non-heme complexes. In: Lukiewiez SJ, Zweier JL, editors. Nitric oxide in allograft rejection and anti-tumor defense. Norwell, MA: Kluwer Academic Publishers; 1998. p. 49-82.
3. Vanin A.F., Malenkova I.V., Mordvintsev O.I., Mülsch A. Dinitrosyl complexes of iron with thiol-containing ligands and their reverse conversion into nitrosothiols. Biokhimiia. 58:1993;1094-1103.
4. Mülsch A., Mordvintcev P., Vanin A.F., Busse R. The potent and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols. FEBS Lett. 294:1991;252-256.
5. Boese M., Mordvintcev P.I., Vanin A.F., Busse R., Mülsch A. S-Nitrosation of serum albumin by dinitrosyl-iron complex. J. Biol. Chem. 270:1995;29224-29229.
6. Boese M., Keese M.A., Becker K., Busse R., Mülsch A. Inhibition of glutathion reductase by dinitrosyl-iron-dithiolate complex. J. Biol. Chem. 272:1997;21767-21773.
7. Keese M.A., Boese M., Mülsch A., Schirmer R.H., Becker K. Dinitrosyl-dithiol-iron complexes, nitric oxide (NO) carriers in vivo, as potent inhibitors of human glutathion reductase and gluthathion-S-transferase. Biochem. Pharmacol. 54:1997;1307-1313.
8. Stoclet J.-C., Troncy E., Muller B., Brua C., Kleschyov A.L. Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system. Exp. Opin. Invest. Drugs. 7:1998;1769-1779.
9. Ueno T., Susuki Y., Fujii S., Vanin A.F., Yoshimura T. In vivo nitric oxide transfer of a physiological NO carrier, dinitrosyl dithiolato iron complex, to target complex. Biochem. Pharmacol. 63:2002;485-493.
10. Muller B., Kleschyov A.L., Malblanc S., Stoclet J.-C. Nitric oxide-related cyclic GMP-independent effect of N-acetylcysteine in lipopolysaccharide treated rat aorta. Br. J. Pharmacol. 123:1998;1221-1229.
11. Wiegant F.A., Malyshev I.Y., Kleschyov A.L., van Faassen E., Vanin A.F. Dinitrosyl iron complexes with thiol-containing ligands and S-nitroso-D,L- penicillamine as inductors of heat shock protein synthesis in H35 hepatoma cells. FEBS Lett. 455:1999;179-182.
12. Giannone G., Takeda K., Kleyschov A.L. Novel activation of non-selective cationic channels by dinitrosyl iron-thiosulfate in PC12 cells. J. Physiol. 529:2000;735-745.
13. Kleschyov AL, Hubert G, Munzel T, Stoclet J-C, Bucher, B. Low molecular mass dinitrosyl nonheme-iron complexes up-regulate noradrenaline release in the rat tail artery. BMC Pharmacol 2002;2:3.
14. Mülsch A. Nitrogen monoxide transport mechanisms. Arzneim-Forsch. 44:1994;408-411.
15. Jia L., Bonaventura C., Bonaventura J., Stamler J.S. S- Nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature. 380:1996;221-226.
16. Vanin A.F. Dinitrosyl iron complexes and S-nitrosothiols are two possible forms for stabilization and transport of nitric oxide in biological systems. Biochemistry (Moscow). 63:1998;782-793.
17. Muller B., Kleschyov A.L., Alencar J.L., Vanin A.F., Stoclet J.-C. Nitric oxide transport and storage in the cardiovascular system. Ann. N.Y. Acad. Sci. 912:2002;131-139.
18. Muller B., Kleschyov A.L., Stoclet J.-C. Evidence for N-acetylcysteine sensitive nitric oxide storage as non haeme dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta. Br. J. Pharmacol. 119:1996;1281-1285.
19. Kleschyov A.L., Muller B., Kéravis T., Stoeckel M.-E., Stoclet J.-C. Adventitia-derived NO in rat aorta exposed to bacterial lipopolysaccharide: cell origin and functional consequences. Am. J. Physiol. 279:2000;H2743-H2751.
20. Vedernikov Y.P., Mordvintcev P.I., Malenkova I.V., Vanin A.F. Similarity between the vasorelaxing activity of dinitrosyl iron cysteine complexes and endothelium-derived relaxing factor. Eur. J. Pharmacol. 211:1992;313-317.
21. Vanin A.F. Endothelium-derived relaxing factor is a nitrosyl iron complex with thiol ligands. FEBS Lett. 289:1991;1-3.
22. Alencar J.L., Lobysheva I., Geffard M., Sarr M., Schott C., Schini-Kerth V., Nepveu F., Stoclet J.-C., Muller B. Role of S-nitrosation of cysteine residues in long-lasting inhibitory effect of NO on arterial tone. Mol. Pharmacol. 63:2003;1148-1158.
23. Mayer B., Pfeiffer S., Schrammel A., Koesling D., Schmidt K., Brunner F. A new pathway of nitric oxide/cyclic GMP signaling involving S-nitrosoglutathione. J. Biol. Chem. 273:1998;3264-3270.
24. Scharfstein J.S., Keaney J.F., Slivka A., Welch G.N., Vita J.A., Stamler J.S., Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest. 94:1994;1432-1439.
25. Vanin A.F., Kiladze S.V., Kubrina L.N. On including of low molecular SH containing compounds in nitrosyl non-haem iron complexes in non-cellular and cellular preparates. Biophysics (USSR). 20:1975;1068-1072.
26. Saville B. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst. 83:1958;670-672.
27. Murphy M.E., Noack E. Nitric oxide assay using hemoglobin method. Methods Enzymol. 233:1994;240-250.
28. Brunk C.F., Jones K.C., James T.W. Assay for nanogram quantities of DNA in cellular homogenates. Anal. Biochem. 92:1979;497-500.
29. Kleschyov A.L., Mollnau H., Oelze M., Meinertz T., Huang Y., Harrison D.G., Munzel T. Spin trapping of vascular nitric oxide using colloid Fe(II)-diethyldithiocarbamate. Biochem. Biophys. Res. Commun. 275:2000;667-672.
30. Gordge M.P., Hothersall J.S., Noronha-Dutra A.A. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione. Br. J. Pharmacol. 124:1998;141-148.
31. Vanin A.F., Stukan R.A., Manukhina E.B. Physical properties of dinitrosyl iron complexes with thiol-containing ligands in relation with their vasodilator activity. Biochim. Biophys. Acta. 1295:1996;5-12.
32. Hiraishi H., Terano A., Ota S., Mutoh H., Sugimoto T., Harada T., Razandi M., Ivey K.J. Protection of cultured rat gastric cells against oxidant-induced damage by exogenous glutathione. Gastroenterology. 106:1994;1199-1207.
33. Deneke S.M., Susanto I., Vogel K.A., Williams C.E., Lawrence R.A. Mechanisms of use of extracellular glutathione by lung epithelial cells and pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 12:1995;662-668.
34. Kleschyov A.L., Mordvintcev P.I., Vanin A.F. Role of nitric oxide and iron in hypotensive action of nitrosyl iron complexes with various anion ligands. Stud. Biophys. 105:1985;93-102.
35. Manukhina E.B., Smirin B.V., Malyshev I.Y., Stoclet J.-C., Muller B., Solodkov A.P., Shebeko V.I., Vanin A.F. Nitric oxide storage in the cardiovascular system. Izv Akad Nauk Ser. 5:2002;585-596.
36. Arnelle D.R., Day B.J., Stamler J.S. Diethyldithiocarbamate-induced decomposition of S-nitrosothiols. Nitric Oxide. 1:1999;56-64.
37. Manukhina E.B., Mashina S.Y.u., Smirin B.V., Lyamina N.P., Senchikhin V.N., Vanin A.F., Malyshev I.Y.u. Role of nitric oxide in adaptation to hypoxia and adaptative defense. Physiol. Res. 49:2000;89-97.
38. Rodriguez J., Maloney R.E., Rassaf T., Bryan N.S., Feelisch M. Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc. Natl. Acad. Sci. U.S.A. 100:2003;336-341.